Effects of Febuxostat for Lowering Uric Acid in NAFLD Patients With Gout

Clinical trial NCT04772352 · UNKNOWN

Trial details

NCT number: NCT04772352
Sponsor: Ningbo No. 1 Hospital
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Fatty Liver Disease

Start date: 2021-03-01
Primary completion: 2021-08-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.